| Aktie | Ticker | Breite | GCS | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 30.189 $ | -17.818 $ | -40,4 % | 2 | 490.183 $ | -225.795 $ | -38,2 % | 3 | ||||
| Currenc Group Inc. | CURR | → 0 | Neutral | 442.176 $ | -273.802 $ | -38,2 % | 1 | ||||
| Aspire Biopharma Holdings, Inc. | ASBP | → 0 | Neutral | 26.762 $ | -15.035 $ | -36,0 % | 1 | 41.797 $ | +41.797 $ | 1 | |
| ASPIRE BIOPHARMA HLDGS INC | → 0 | 3.427 $ | -2.783 $ | -44,8 % | 1 | 6.210 $ | +6.210 $ | 1 | |||
| 30.189 $ | -17.818 $ | -40,4 % | 2 | 490.183 $ | -225.795 $ | -38,2 % | 3 | ||||